Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer

Journal of Experimental and Clinical Cancer Research

Volumn 32, Issue 1, 2013, Pages

  Wang, Zishu ^a   Wang, Jin ^b   Yang, Yan ^a   Hao, Bo ^a   Wang, Rui ^a   Li, Yumei ^a   Wu, Qiong ^a  

^a BENGBU MEDICAL COLLEGE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; hsa miR 337 3p; Metastasis; miRNA; miRNA array

Indexed keywords

MICRORNA; MICRORNA 134; MICRORNA 30C; MICRORNA 337 3P; MICRORNA 483 5P; MICRORNA 508 5P; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; STOMACH CANCER; TUMOR INVASION; UPREGULATION;

CELL GROWTH PROCESSES; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MICRORNAS; PROGNOSIS; STOMACH NEOPLASMS; TRANSFECTION; UP-REGULATION;

EID: 84885467135     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-32-76     Document Type: Article

References (27)

1. Treatment strategy for early gastric cancer. Wang J, Yu JC, Kang WM, Ma ZQ, Surg Oncol 2012 21 119 123 10.1016/j.suronc.2010.12.004 21256735
2. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, Int J Cancer 2010 127 2893 2917 10.1002/ijc.25516 21351269
3. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. Kamangar F, Dores GM, Anderson WF, J Clin Oncol 2006 24 2137 2150 10.1200/JCO.2005.05.2308 16682732
4. Detecting the recurrence of gastric cancer after curative resection: comparison of FDG PET/CT and contrast-enhanced abdominal CT. Kim DW, Park SA, Kim CG, J Korean Med Sci 2011 26 875 880 10.3346/jkms.2011.26.7.875 21738339
5. Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survival. Rohatgi PR, Yao JC, Hess K, Schnirer I, Rashid A, Mansfield PF, Pisters PW, Ajani JA, Cancer 2006 107 2576 2580 10.1002/cncr.22317 17075877
6. MicroRNA function in animal development. Wienholds E, Plasterk RH, FEBS Lett 2005 579 5911 5922 10.1016/j.febslet.2005.07.070 16111679
7. MicroRNAs: genomics, biogenesis, mechanism, and function. Bartel DP, Cell 2004 116 281 297 10.1016/S0092-8674(04)00045-5 14744438
8. Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells. Zhao X, Yang L, Hu J, J Exp Clin Cancer Res 2011 30 55 10.1186/1756-9966-30-55 21569481
9. miRNA profiling for diagnosis and prognosis of human cancer. Jay C, Nemunaitis J, Chen P, Fulgham P, Tong AW, DNA Cell Biol 2007 26 293 300 10.1089/dna.2006.0554 17504025
10. Circulating microRNAs in cancer: origin, function and application. Ma RM, Jiang T, Kang XX, J Exp Clin Canc Res 2012 31 38 10.1186/1756-9966-31-38
11. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. Li BS, Zhao YL, Guo G, Li W, Zhu ED, Luo X, Mao XH, Zou QM, Yu PW, Zuo QF, et al. PLoS One 2012 7 41629 10.1371/journal.pone.0041629 22860003
12. Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer. Kang W, Tong JH, Chan AW, Lung RW, Chau SL, Wong QW, Wong N, Yu J, Cheng AS, To KF, PLoS One 2012 7 33919 10.1371/journal.pone.0033919 22470493
13. miR-21 is a promising novel biomarker for lymph node metastasis in patients with gastric cancer. Xu Y, Sun J, Xu J, Li Q, Guo Y, Zhang Q, Gastroenterol Res Pract 2012 2012 640168 22792096
14. Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK. Wang M, Li C, Nie H, Lv X, Qu Y, Yu B, Su L, Li J, Chen X, Ju J, et al. FEBS Lett 2012 586 2382 2388 10.1016/j.febslet.2012.05.050 22677169
15. Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma. Martin-Perez D, Vargiu P, Montes-Moreno S, Leon EA, Rodriguez-Pinilla SM, Lisio LD, Martinez N, Rodriguez R, Mollejo M, Castellvi J, et al. Leukemia 2012 26 180 183 10.1038/leu.2011.189 21788950
16. Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM, Gao HJ, J Dig Dis 2010 11 50 54 10.1111/j.1751-2980.2009.00413.x 20132431
17. Down-regulated miR-9 and miR-433 in human gastric carcinoma. Luo HC, Zhang HB, Zhang ZZ, Zhang X, Ning B, Guo JJ, Nie N, Liu B, Wu XL, J Exp Clin Canc Res 2009 28 82 10.1186/1756-9966-28-82
18. The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma. Patterson E, Webb R, Weisbrod A, Bian B, He M, Zhang L, Holloway AK, Krishna R, Nilubol N, Pacak K, et al. Endocr Relat Cancer 2012 19 157 166 10.1530/ERC-11-0308 22241719
19. miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Soon PS, Tacon LJ, Gill AJ, Bambach CP, Sywak MS, Campbell PR, Yeh MW, Wong SG, Clifton-Bligh RJ, Robinson BG, et al. Clin Cancer Res 2009 15 7684 7692 10.1158/1078-0432.CCR-09-1587 19996210
20. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1. Nagel S, Scherr M, Kel A, Hornischer K, Crawford GE, Kaufmann M, Meyer C, Drexler HG, MacLeod RA, Cancer Res 2007 67 1461 1471 10.1158/0008-5472.CAN-06-2615 17308084
21. A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene. Bezrookove V, van Zelderen-Bhola SL, Brink A, Szuhai K, Raap AK, Barge R, Beverstock GC, Rosenberg C, Cancer Genet Cytogenet 2004 149 72 76 10.1016/S0165-4608(03)00302-9 15104287
22. miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers. Du L, Subauste MC, Desevo C, Zhao Z, Baker M, Borkowski R, Schageman JJ, Greer R, Yang CR, Suraokar M, et al. PLoS One 2012 7 39167 10.1371/journal.pone.0039167 22723956
23. Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions. Yin W, Cheepala S, Roberts JN, Syson-Chan K, DiGiovanni J, Clifford JL, Mol Cancer 2006 5 15 10.1186/1476-4598-5-15 16603078
24. Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor. Alvarez JV, Greulich H, Sellers WR, Meyerson M, Frank DA, Cancer Res 2006 66 3162 3168 10.1158/0008-5472.CAN-05-3757 16540667
25. Rap GTPase-mediated adhesion and migration: a target for limiting the dissemination of B-cell lymphomas? Lin KB, Freeman SA, Gold MR, Cell Adh Migr 2010 4 327 332 10.4161/cam.4.3.11114 20212359
26. Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma. Hauser S, Wulfken LM, Holdenrieder S, Moritz R, Ohlmann CH, Jung V, Becker F, Herrmann E, Walgenbach-Brunagel G, von Ruecker A, et al. Cancer Epidemiol 2012 36 391 394 10.1016/j.canep.2012.04.001 22542158
27. MicroRNA profiling of human gastric cancer. Yao Y, Suo AL, Li ZF, Liu LY, Tian T, Ni L, Zhang WG, Nan KJ, Song TS, Huang C, Mol Med Report 2009 2 963 970